CJC-1295 (No DAC) + IPA (10mg)
Description & mechanism
This preparation combines CJC-1295 without DAC (an extended-half-life GHRH analogue) with ipamorelin (a ghrelin-receptor agonist secretagogue). It is used in research to study combined GHRH- and ghrelin-receptor signalling on the growth-hormone axis in endocrine cell models.
Applications in research
- Combined GHRH and GHS-R1a receptor activation studies
- Synergistic growth-hormone release in pituitary models
- Endocrine-axis signalling experiments
Specifications
Handling, reconstitution & storage
Reconstitute the lyophilized solid in sterile water or bacteriostatic diluent to the desired working concentration; mix by gentle inversion and avoid vigorous agitation or repeated freeze-thaw. Sterile-filter (0.22 µm) if aseptic use is required, aliquot into single-use volumes, and store reconstituted material frozen at -20 °C.
Precautions & notes
For in-vitro research and laboratory use only. Bodily introduction of any kind into humans or animals is strictly forbidden. Handle as a bioactive substance using appropriate PPE and consult the safety data sheet. Note: these compounds may fall under the World Anti-Doping Agency Prohibited List (e.g. S2); this designation concerns competitive sport and is unrelated to research use.
This product is furnished for in-vitro research and laboratory use only. Bodily introduction of any kind into humans or animals is strictly forbidden.